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Tactics and Economics of Wildlife
Oral Rabies Vaccination, Canada
and the United States
Ray T. Sterner, Martin I. Meltzer, Stephanie A. Shwiff, and Dennis Slate

Progressive elimination of rabies in wildlife has been a
general strategy in Canada and the United States; common
campaign tactics are trap–vaccinate–release (TVR), point
infection control (PIC), and oral rabies vaccination (ORV).
TVR and PIC are labor intensive and the most expensive
tactics per unit area (≈$616/km2 [in 2008 Can$, converted
from the reported $450/km2 in 1991 Can$] and ≈$612/km2
[$500/km2 in 1999 Can$], respectively), but these tactics
have proven crucial to elimination of raccoon rabies in Canada and to maintenance of ORV zones for preventing the
spread of raccoon rabies in the United States. Economic assessments have shown that during rabies epizootics, costs
of human postexposure prophylaxis, pet vaccination, public
health, and animal control spike. Modeling studies, involving diverse assumptions, have shown that ORV programs
can be cost-efficient and yield benefit:cost ratios >1.0.

R

abies continues to pose major public health concerns in
Canada and the United States (1–5). Effective pet vaccination programs have controlled rabies in domestic dogs
(Canis familiaris) in both countries, but rabies persists in
wildlife reservoirs. In 2007, a total of 6,776 cases in wildlife were reported for the contiguous United States (1).
Oral rabies vaccination (ORV) is an evolving rabies
control technology for use in wildlife (6). It involves distribution of baits containing orally immunogenic vaccines
onto the landscape, thereby targeting wildlife to establish
population immunity and prevent spread or eliminate specific rabies variants (6).
We reviewed the literature on ORV programs and
economics in Canada and the United States. The first use
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of ORV sought to control rabies in red foxes (Vulpes vulpes) in Switzerland; subsequent programs were reported
throughout much of western Europe (7,8). Switzerland,
France, Belgium, and Luxembourg were deemed free of
the red fox variant by 2001 (8).
ORV in Ontario, Canada
Arctic Fox–Variant Rabies in Red Foxes

During 1989–1995, ORV was used in Ontario to progressively eliminate arctic fox (Alopex lagopus)–variant
rabies that had spilled into (i.e., had been transmitted to
another species) red foxes and spread southward (9). Each
year ORV baits were distributed in southern Ontario (≈20
baits/km2, from aircraft or by hand, over 8,850–29,590
km2). The strategy was termed progressive elimination and
resembled an expanding ORV wedge, which started near
the center of the outbreak and expanded during successive
years (Figure 1).
Within 5 years of program initiation, reported cases of
rabid foxes declined from 203 cases/year to 4 cases/year in
the baited areas (9,10). Spillover cases from red foxes to
striped skunks (Mephitis mephitis) and livestock dropped
from preepizootic (30-year) means of >36 and >42, respectively, to 0 by 1997 (9). Since 2003, only 13 cases of the
variant in red foxes have been reported; these continue to
be addressed by using focused control and enhanced surveillance (i.e., increased public health monitoring, examination of road-killed target animals, and rabies analyses of
samples from trappers) (D. Donovan, Ontario Ministry of
Natural Resources, pers. comm.).
Rabies in Raccoons and Skunks

During 1987–1991, to reduce spillover of rabies from
red foxes to urban raccoons (Procyon lotor) and skunks,
trap–vaccinate–release (TVR; capture live, vaccinate parenterally, and release on site) was integrated into ORV

Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 8, August 2009

Tactics and Economics of Oral Rabies Vaccination

mouth of the St. Lawrence River using similar tactics was
recently reported (13).
ORV in the United States
Canine-Variant Rabies in Coyotes in Southern Texas

Figure 1. Expanding-wedge tactic with progressive elimination
(9). Numbers represent successive oral rabies vaccination (ORV)
zones. Potential savings are assumed for the area of progressive
elimination, southern Ontario Province. The rectangle bordering the
rabies source (i.e., 5) highlights an area of enhanced surveillance,
possible point infection control (PIC) activities, trap–vaccinate–
release (TVR) activities, or an ORV zone intended to deter future
reemergence of the virus.

campaigns in the Toronto area (10). TVR was part of
the red fox ORV program because Evelyn-RokitnickiAbelseth oral rabies vaccine is not immunogenic in skunks
and raccoons (6,9). Live traps were set (20–75 traps/km2)
in a 60-km2 portion of the city, and 66,168 ORV baits were
distributed by hand in natural areas (20–40 baits/km2). Of
sampled foxes, 46%–80% had biomarkers from baits, and
only 1 rabid fox was found during 1987–1992 (10). A recent update of ORV baiting in Toronto stated that 332,257
baits had been distributed during 1989–1999, and only 5
rabid foxes were found during 1990–2006 (11).
During 1999–2000, the raccoon variant of rabies was
confirmed near Brockville, Ontario (12). To eliminate
raccoon-variant rabies from the province, a point infection
control (PIC) tactic, which integrated population reduction
(PR; sometimes referred to as culling or depopulation),
TVR, and ORV, was implemented (12). The initial PIC operation included concentric zones, each consisting of 1) an
inner 5-km PR zone, 2) a middle 5-km TVR zone, and 3)
an outer 8–15-km ORV zone (Figure 2). Additional PIC or
modified PIC (no PR) operations were centered on newly
discovered rabid raccoons (≈40).
Mean raccoon densities in PR zones dropped from
5.1–7.1/km2 before to 0.6–1.1/km2 after PIC operations.
However, within 1 year, >37 more cases of raccoon-variant rabies occurred in the PIC regions (12). Intensive PIC
was begun again and eliminated the variant from Ontario.
Subsequently, to reduce the chances of raccoon-variant
rabies recurring in southern Ontario, enhanced surveillance and annual ORV was conducted along the border
of Ontario and New York (D. Donovan, pers. comm.).
Elimination of raccoon rabies from Wolfe Island at the

During 1988–1994, a canine-variant of rabies described in Mexico was confirmed in 163 domestic dogs and
296 coyotes from 18 counties in southern Texas (14–16). In
1995, to prevent the northward spread of this variant, ORV
baits (9–27 baits/km2) were distributed in an arc-shaped
band over a 24-county area (39,850 km2) ≈200 km north
of Laredo (16). During 1996–2003, annual baiting continued; ≈9.35 million baits were distributed onto ≈741,766
km2 (17). Gradually, baits were distributed farther south,
toward the Rio Grande River, in subsequent years, thereby
collapsing the rabies-infected area (Figure 3). To protect
livestock, coyotes were also removed from portions of the
ORV zone during these years, but the effect of PR relative
to ORV was not assessed (18,19). PR is considered an important component of many rabies-control models (20).
After 1 year of baiting, the mean rate of canine-variant cases at the leading edge of the epizootic area was
2.8/10,000 km2. This rate was similar to that of the preepizootic period and suggestive that the northward spread of
the epizootic had ceased (16). Subsequent surveillance
showed a gradual decline in cases from 122 in 1995 to 0
in 2004 (17). Currently, to maintain an immune buffer and
prevent canine rabies from reemerging in southern Texas,
this program baits an ORV zone 30–65 km wide along the
international border each year (E. Oertli, Texas Department
of State Health Services, pers. comm.).

2ndrabies
source
3rdrabies
source
ORV
1strabies
source

TVR
PR

Figure 2. Point infection control (PIC) tactic. Concentric rings
around the location of a rabid animal represent vector population
reduction (PR), trap–vaccinate–release (TVR), and ORV zones
(12). Each new source leads to repeated, overlapping ORV, TVR,
and PR rings. Potential savings are assumed within the zones and
for assumed distances beyond the zones.
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(E. Oertli, pers. comm.). The rabies-control goal has not
changed from one of containment and elimination of the
gray fox variant from Texas. However, in light of recent
surveillance, the anticipated strategy of establishing and
maintaining an ORV zone along the Rio Grande River to
prevent potential reemergence from Mexico has been delayed and is being refined to include prolonged enhanced
surveillance as a key factor in allocating resources and
gauging success (E. Oertli, pers. comm.).
Raccoon-Variant Rabies in the Eastern United States

Figure 3. Collapsed-bands tactic with progressive elimination (17).
Numbers represent successive oral rabies vaccination (ORV)
zones that attempt to collapse the baited area, exclude virus
incursion outside, and lead to a maintenance zone that prevents
reintroduction of the disease after the current population matures
and vaccination effects are lost. Potential savings are assumed to
occur within the ORV areas and for assumed distances beyond the
zone. The rectangle bordering the rabies source (i.e., 5) high-lights
an area of enhanced surveillance, possible point infection control
(PIC) activities, trap–vaccinate–release (TVR) activities, or an ORV
zone intended to deter future reemergence of the virus.

The National Rabies Management Program began in
1997 and coordinates ORV and related wildlife rabies–
control activities in the United States (21,22). One of its
priorities is to prevent the spread of raccoon-variant rabies
into uninfected areas, particularly west of its current distribution along the Appalachian Ridge (22). The Program integrates natural terrain features (e.g., rivers, lakes, and poor
habitat along mountain ridges) with ORV zones (baited at
50–75 baits/km2) to create a 40–50 km zone of vaccinated
raccoons to help prevent the spread of the virus (Figure 5).
During 1997–2007, the ORV zone was expanded from
parts of Ohio to encompass parts of 8 states (i.e., Ohio,
Pennsylvania, West Virginia, Virginia, Tennessee, North
Carolina, Georgia, and Alabama) along the Appalachian
Ridge. A total of 58 bait distributions (usually 1/year) total-

Gray Fox–Variant Rabies in West-Central Texas

During 1988–1994, a total of 283 gray foxes (Urocyon cinereoargenteus) and 241 other domestic and wild
animals in west-central Texas were confirmed positive for
a unique rabies variant typically found in gray foxes (17).
This outbreak was spatially distinct from the outbreak of
canine rabies in southern Texas. To control this epizootic,
during 1995–2009 (and ongoing), ORV (29–39 baits/km2)
was conducted annually by encircling the epizootic area
using ≈32-km–wide ORV strips; an added 16- to 24-km
vaccination buffer of ORV baits was created along the
northern and eastern edges of the rabies-variant area; this
tactic has been referred to as a purse string–like tactic (i.e.,
encircle and shrink) (17; Figure 4). An area of ≈350,000
km2 was baited annually. Evidence of bait biomarkers
and positive rabies virus neutralizing antibody titers was
found for 39% and 62% of foxes, respectively, sampled
from the ORV zone, confirming that numerous foxes had
been vaccinated.
In 2007, new cases of gray fox rabies occurred northwestward along the Pecos River and in west-central Texas.
To prevent further spread of this variant, ORV was used
1178

Figure 4. Purse string–like tactic with progressive elimination (17).
Numbers represent successive oral rabies vaccination (ORV) zones
that attempt to roughly encircle and shrink the baited area, exclude
virus incursion from outside, and lead to a maintenance zone that
prevents reintroduction of the disease after the current population
matures and vaccination effects are lost. Potential savings are
assumed to occur within the ORV areas and for assumed distances
beyond the outer zone. The rectangle bordering the rabies source
(i.e., 5) highlights an area of enhanced surveillance, possible point
infection control (PIC)/trap–vaccinate–release (TVR) activities, or
an ORV zone intended to deter future reemergence of the virus.
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ing ≈41,018,800 baits and covering ≈530,825 km2 (range of
28,660 km2 to 84,225 km2/distribution) have characterized
this effort as of 2007 (R. Hale, US Department of Agriculture, pers. comm.). On the basis of rates of spread of 30–60
km/year in the Mid-Atlantic states before 1997 (22–24),
ORV is viewed as having slowed movement of the virus
and, with contingency actions to eliminate some dispersed
cases, prevented westward spread of rabies among raccoons. Relatively low and variable vaccination rates have
been found, despite the use of relatively high bait densities
(50–100/km2). Estimated raccoon vaccination rates, based
solely on the index of rabies virus neutralizing antibody response, range from 10% to 55% (22). The need to vaccinate
annually is dictated mainly by high death rates for juveniles
and a relatively young age structure for raccoons in North
America; juveniles often account for 50% of raccoon populations (22). Still, enhanced and public health surveillance
indicate that areas west of the Appalachian Ridge remain
free of raccoon-variant rabies (1,22,23).
To maintain the integrity of the Appalachian Ridge
ORV zone, contingency actions have been needed. In 2004,
emergency ORV baiting and TVR were used in northeast
Ohio between the established ORV zone and the eastern
suburbs of Cleveland (25). TVR of >300 raccoons and multiple ORV distributions occurred in this contingency action. This ORV zone had been widened earlier because of
encroachment of rabid raccoons from Pennsylvania (26).
Other contingency actions unrelated to the westward
spread of raccoon rabies have also been implemented. In
2004, an ORV zone created near the Cape Cod Canal to prevent spread of raccoon-variant rabies onto Cape Cod, Massachusetts, was breached, and raccoon-variant rabies spread
rapidly throughout the peninsula (T. Algeo, US Department
of Agriculture, pers. comm.). Currently, ORV is used twice
a year (spring and fall) in the eastern half of the Cape, and
baiting is moved gradually westward until an ORV zone
can be reestablished along the Cape Cod Canal (J.C. Martin, Tufts Cummings School of Veterinary Medicine, pers.
comm.). Additionally, to prevent raccoon rabies from reemerging in southern Ontario, ORV baiting for raccoonvariant rabies continues in northern New York. Confirmed
positive raccoon-variant cases in southern Quebec have led
to extensive PIC and ORV campaigns to prevent the disease
from reaching Montreal. Together, these events and contingency actions illustrate the challenges posed by raccoon
rabies, the importance of enhanced surveillance, plus the
need to anticipate unexpected contingency actions and their
related costs as a component of ORV campaigns.
Rabies-related Costs
Several studies have documented the costs associated with wildlife-rabies epizootics (27–31; see online
Technical Appendix 1, available from www.cdc.gov/EID/

Figure 5. Oral rabies vaccination (ORV) preventive spread or
elimination tactic with eventual progressive elimination (22). The
ORV zone of vaccinated animals is intended to prevent spread of
the disease beyond the ORV zone; potential elimination is assumed
to result from successive baiting campaigns into the infected area.
Potential savings are assumed beyond the ORV zone (or within the
zone, if elimination is possible); disease spread rates, final distances
of infectious impacts, and durations of ORV bait distributions
ultimately determine the magnitude of potential savings. PIC, point
infection control activities; TVR, trap–vaccinate–release activities.

content/15/8/1176-Techapp1.pdf). Costs have been adjusted for inflation to 2008 US$ or Can$. A raccoon-variant rabies epizootic in the early 1990s in Hunterdon and
Warren Counties, New Jersey, more than doubled rabiesrelated control costs from $6.67/county resident at $591/
km2 ($4.05/county resident and $359/km2, US$ in 1990) to
$16.13/county resident at $1,503/km2 ($9.79/county resident at $913/km2, US$ in 1990) (27).
In Massachusetts, a multiyear study found that the median cost of postexposure prophylaxis (PEP) was $3,356/
patient ($2,376/patient; range $1,038–$4,447, US$ in
1995); 69% of the cost was for biologics (28). Numbers of
PEP administrations increased 26-fold, from 1.7/100,000
residents in 1991 to 45/100,000 residents in 1995 (28). Estimates for Connecticut were similar (29).
A raccoon-variant epizootic in New York State began in 1991, and the resultant rate of PEP administrations
ranged from the equivalent of 24 to 34/100,000 residents
(no preepizootic estimates of PEP given) (30). During
1998–1999, the mean PEP cost was $1,501/person treated
($1,136/person, US$ in 1998; biologics and administration), equivalent to between $36,024 and $51,034/100,000
residents ($27,264 and $38,624/100,000, US$ in 1998);
New York City’s population is excluded from these estimates. This lower cost compared with that for Massachusetts (28) and Connecticut (29) may be the result of local
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public health department coordination of PEP administrations in New York State (30).
Recently (1998–2002), rabies exposure costs were estimated at $4,066/patient ($3,688/patient, US$ in 2005) in
southern California (31). Average direct (biologics, medical costs) and indirect costs (travel to physicians, day care
for medical appointments) were estimated at $2,827/patient and $1,239/patient, respectively ($2,564/patient and
$1,124/patient, US$ in 2005).
ORV Program Costs
Bait costs and detailed descriptions of the areas baited,
which allowed computations of unit area expenses, are available in Table 1 and online Technical Appendix 2 (available
from www.cdc.gov/EID/content/15/8/1176-Techapp2.pdf).
ORV programs in Canada and the United States have lasted
from >1 for some to >11 years for others and have often
required integration of contingency actions (Table 1). The
most expensive tactics have been labor-intensive PIC and
TVR, but their effectiveness is crucial to maintaining the
overall integrity of certain ORV campaigns (10–13,22,25).
PIC programs have been reported to cost $612/km2 ($500/

km2, Can$ in 1999); costs reported for 3 PIC operations
for raccoons totaled $469,247 ($363,100, Can$ in 1999;
12). TVR costs have ranged from $616/km2 to $1,573/km2
($450/km2 to $1,150/km2, Can$ in 1991; Table 1).
The target species of ORV greatly affects costs,
mainly because of species-specific, bait-density requirements. Bait densities for foxes and coyotes have been less
than half those for raccoons (Table 1). Thus, gray fox and
coyote ORV programs in Texas averaged $48/km2 ($42/
km2, US$ in 2004; Table 1), and raccoon programs in the
eastern United States averaged between $111/km2 ($108/
km2, US$ in 2007) and $198/km2 ($153/km2, US$ in 1999).
Cumulative cost of the Appalachian Ridge ORV program
has totaled ≈$57 million since its inception in 1997; baits
accounted for 72% of the funds expended (Tables 1, 2).
Annual costs vary as changes in ORV zones occur,
as contingency actions occur, and as ORV programs shift
from preventing spread to eliminating variants in given
geographic areas. Individual bait prices in the United States
range from $1.00 to $1.25 (US$ in 2008, depending on bait
type). Because of improved production efficiency, bait
prices have decreased slightly during the past 5 years.

Table 1. Major oral rabies vaccination campaigns, Canada and the United States*
Target bait
density,
ORV, TVR, or
2
2
no./km
PIC area, km /y†

Duration,
y

Target
species

Unit bait cost

>7§

Red fox

Not reported

18–20

8,850–31,460

No estimate

(10)

ORV progressive
elimination
TVR

5§

>$2.00
(Can$ 1991)

20/den
fox only

60

$450–$1,150
(Can$ in 1991)

(12)

PIC

>1§

Skunk,
raccoon,
red fox
Raccoon

>$2.00
(Can$)

70

225 PR, 485
TVR, 1,200 ORV

$500
(Can$ in 1999)

ORV zone
(Appalachian Ridge)
ORV zone (Ohio–
Pennsylvania border)

>1§

Raccoon

$1.22 (US$)

50–75

28,659–84,225

4§

Raccoon

$1.37–$1.52
(US$)

75

3,872–6,497

ORV progressive
elimination
ORV progressive
elimination

>9§

Coyote

Not reported

19–27

38,850

>8§

Gray fox

Not reported

27–39

56,202

$108
(US$ in 2007)
$153; range
$102–$262
(US$ in 1999)¶
$42
(US$ in 2004)#
$42
(US$ in 2004)#

Country and
reference
Canada
(9)

United States§
D. Slate, unpub.
data (2007)
(26)
(17)
(17)

Strategy or tactic

2

Cost/km ‡

*Unless otherwise noted, costs are in Can$ or US$. No discounting for inflation was used; this article and online Technical Appendix 2
(www.cdc.gov/EID/content/15/8/1176-Techapp2.pdf) provide inflation-corrected costs in 2008 Can$ or US$.
†Components of reported areas differ according to tactic and strategy. Oral rabies vaccination (ORV) entails topographic areas at which baits are
distributed at target densities over landscape. Trap–vaccinate–release (TVR) involves relatively limited topographic areas of intense live trapping and
parenteral vaccination of captured animals. Point infection control (PIC) involves successive concentric rings of population reduction, TVR and ORV; the
concentric rings become distorted if subsequent rabid animals are caught within these rings. New concentric rings are now formed according to these
occurrences. Additionally, depending on habitat or location of urban centers, ORV may be used in a larger strip to create an added ORV preventive zone.
‡Most cost estimates include purchase of baits, aircraft, fuel, and equipment but often omit accurate labor charges.
§Surveillance, TVR, PIC, or ORV bait distributions continue at present; therefore, current duration and areas baited differ from those reported. According
to Foroutan et al. (26), ORV baitings continue as part of the National ORV Program (Slate et al. [22]).
¶According to Foroutan et al. (26), areas were baited twice each year. In 1997, the first baiting was conducted over a smaller area (1,780 km2), and in
May 1997 (initial) and June 1999, 2 smaller emergency baitings (in response to a breach in the ORV zone) were conducted, covering <1,701 km2.
Average costs include a baiting in April 1999, when several tests of bait densities (high) were conducted.
#According to Sidwa et al. (17), the area baited had shrunk over time because of progressive coyote-variant rabies elimination, but the purse string (gray
fox) tactic and ORV-baited area were expanded in 2007 as the gray fox variant spread north along the Pecos River and into southern Texas. The area
cost estimate was derived as the quotient of a reported $3.8 million/year program cost and average annual 33,669 km2 (dog and coyote) and 56,202 km2
(gray fox) bait zones (sum 89,871 km2) cited in online Technical Appendix 2.
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Table 2. Approximate, undiscounted total costs of largest oral rabies vaccine programs, North America, 1989–2004*
Total undiscounted
Average undiscounted
costs, million $
annual costs, million US$
Location, target species
Years
Reference
Ontario, red foxes
1989–2000
Can$43†
3.5
S.A. Shwiff, unpub. data*
Texas, coyotes and gray foxes
1995–2003
US$34
3.8
(17)‡
Appalachian Ridge, raccoons
1997–2007
US$57
5.2
D. Slate, unpub. data§

*Costs are estimates in Can$ or US$ as reported in original publication or as cited by unpublished source.
†S.A. Shwiff et al. (unpub. data) based their calculations on certain data presented in 9,32.
‡Sidwa et al. (17) stated that (for both programs combined) average annual costs were $3.8 million. We computed this value as follows: 9 years × $3.8
million = $34 million total (i.e., Sidwa et al. did not clarify what was included in their cost estimate).
§D. Slate (2007, unpub. data) provided air, bait, fuel, and staff costs, although some staff hours and fuel costs were omitted for initial campaigns during
1997–2001; a total of 9,394 staff hours, $5,868,262 aircraft costs, $923,481 fuel costs, and $50,187,380 bait costs were reported for 58 campaigns
involving the dispensing of 41,018,811 baits over 530,825 km2. The software used to determine bait distribution costs was prepared by staff of the United
States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Rabies Management Program. After deselecting
the bait zones, flight lines were drawn by using the topography (e.g., avoiding water and residential areas) to determine the flight lines and transects. After
that had been established, the bait zones were populated with the lines and measured to determine the total length (km). Flight lines determine total flight
hours: ([km × 0.539958 nautical miles]/flight speed [knots] = flight hours). Fuel usage is computed as follows: (flight hours × consumption rate [91
gallons/h] × fuel price/gallon = total fuel cost). Costs were also influenced by air transect width, distance to airports for refueling, and end-of-transect
turning distance.

Potential ORV-Induced Savings
One ex post study (actual returns, after the fact) provided detailed estimates of PEP administrations in Ontario
during 1956–2000 (32). Annual PEP administrations increased from ≈1,000/year during the 1960s and 1970s to
>2,000/year during 1982–1993, then decreased to ≈1,000/
year again after large-scale ORV campaigns targeting red
foxes began in 1989 (9,10,32). Many factors could account
for these changes, including revisions of PEP administration guidelines. The initial increase in PEP administrations
possibly occurred as a result of fewer adverse effects from
use of the new human diploid cell vaccine and stability in
numbers of rabies cases (32). The latter decrease in PEP administrations was coincident with ORV-caused elimination
of arctic fox–variant rabies from southern Ontario (9).
Modeling the Benefits and Costs of ORV
Measured costs of an epizootic of raccoon rabies in
New Jersey were used to model the costs and benefits of a
hypothetical ORV program (27). The model projected net
savings for ORV (Table 3) based on the assumptions that
the ORV program would require a 2-year campaign and
that expenditures to protect human health would remain
constant. The model did not allow for reintroduction of rabies or for the potential reemergence of rabies. Benefit:cost
ratios (BCRs) related to this hypothetical use of ORV were
reported as >2.2 (27; online Technical Appendix 3, available from www.cdc.gov/EID/content/15/8/1176-Techapp3.
pdf) summarizes key principles of benefit:cost modeling).
Use of ORV to eliminate raccoon rabies from a hypothetical area of 34,447 km2 was modeled under 2 scenarios (33). Scenario 1 assumed that concentric ORV zones
(rings) would expand outward from a center over a 20-year
period and that the ORV zone would be maintained for 10
more years to prevent reintroduction. Scenario 2 assumed
that the entire area would be baited in the first 2 years and
that a ring-shaped ORV zone would be maintained for 28
more years. In the first scenario, inclusion of an expected

20% increase in pet vaccinations (27) as a benefit resulted
in $3.1 million net savings from ORV; removing pet vaccinations as a savings yielded a net cost of $7.7 million
($6.2 million, US$ in 2000; Table 3). The second scenario
yielded no net savings unless the cost of maintaining a containment zone was removed from the model (33).
The economics of a large-scale ORV program to prevent the westward spread of raccoon-variant rabies in the
eastern United States was modeled and used in planning
the current Appalachian Ridge program (34). Scenarios
assumed that a raccoon-variant rabies epizootic would advance in 40 or 127 km/year (fixed rates) bands to the west
of the current leading edge of raccoon-variant rabies along
the Appalachian Ridge (22). Input variables were as follows: 7% discount rate, 102,650 km2 ORV zone, 75 baits/
km2, $1.63/bait ($1.30/bait, US$ in 2005), $10.78/km2
($8.62/km2, US$ in 2000) aerial distribution, and $18.75/
km2 ($15.00/km2, US$ in 2000) post-ORV evaluation. The
effect of an epizootic was calculated in terms of unit human
population within bands. Results showed that all 8 scenarios, except the 40 km/year spread rate with 20-year fixed
baiting costs, yielded BCRs >1.1 and that total estimated
net present values of the program were $48–496 million
with >$96 million in discounted program costs (34). Because of natural geographic features, raccoon population
dynamics, and other factors that affect the spatial and temporal spread of rabies, an assumed variable spread of the virus westward would have been more realistic (25,26). As in
previous models (27,33), estimates of net savings (>50%)
for scenarios were enhanced by inclusion of potential pet
vaccination costs.
Another model examined specific costs of baiting
campaigns for raccoon rabies along the Ohio–Pennsylvania
border (26). This model incorporated movement and lifecycle data for rabid and nonrabid raccoons. An area of 400
km2 with a 10-km ORV zone was assumed to be baited.
Benefits were predicted to accrue mainly in a 5-km strip
on the west side of the ORV zone. Assumptions about rac-
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coon carrying capacity and percentage ORV vaccination
efficiency influenced the rate of rabies spread. This model
predicted a net cost for ORV; however, a simple extrapolation implied that net savings would have occurred if the
benefits were projected for a 100-km strip west of the ORV
zone (26).
Ex post modeling was conducted for the ORV campaigns that eliminated red fox–vectored rabies in Ontario.
Estimated ORV benefits (PEP + animal rabies tests + live-

stock indemnity) ranged from $35.4 million to $99.3 million ($35 million to $98 million, Can$ in 2007; total program costs were $78.0 million ($77 million, Can$ in 2007)
(S.A. Shwiff, unpub. data). BCRs ranged from 0.49 to 1.36,
and outputs implied a lag effect for savings; BCRs were
<1.0 during 1990–1992 and >1.0 during 1993–2000.
Recently, an ex post modeling analysis was performed
for the 1995–2006 ORV program that eliminated caninevariant rabies from southern Texas (16,17,35). Total expen-

Table 3. Comparison of selected modeling studies that examined the economics of oral rabies vaccination programs*
Duration Cost and density of
Locale, tactics,
Type of study,
modeled,
vaccine baits;
y
distribution costs†
Reference
target species
model
Results
Comments
(27)
2 counties in
Benefit:cost, cost
5
$1–$2/bait; 62–200 Net savings $13.34– Probably unrealistic:
2
$20.78/ county
New Jersey,
data collected from
baits/km ;
assumed only 2
resident (1990 US$);
ORV, raccoon
distribution
field with
baitings; no
2
2
$100/km
hypothetical baiting
contingency costs;
$1,244/km –
2
program
main economic
$1,939/km
benefit = reduced pet
vaccinations
30
$1.50/ bait; 100
Benefit:cost of
(33)‡
Hypothetical
Net savings of $3.1 Lack of data required
2
2
baits/km (range
hypothetical baiting
many assumptions;
34,447 km million if reduced pet
bait density, cost/
area, expanding program, extensive
40–115);
vaccinations included
2
sensitivity analyses
bait, and value of pet
circle then
distribution $39/km
as benefit. Net cost
vaccinations were the
maintained
(maximim $100/
($6.2 million) if pet
2
most critical elements
km )
barrier zone,
vaccinations
raccoon
excluded.
20
$1.30/bait, 75
(34)§¶
Appalachian
Benefit:cost model
Net savings $100–
Assumed that without
2
baits/km ; aerial
Ridge area,
of program to deter
$500 million (2000
ORV, rabies would
ORV, raccoon
US$)
distribution $8.62/
westward spread of
move 42 or 125 km/y
2
raccoon rabies
km ; evaluation
west; distribution
2
$15/km
costs are low; animal
vaccinations are
critical component
(26)#
Ohio–
Net costs (1999 US$;
Complex model
Simulation of
40
$1.47/bait; 3
Pennsylvania,
savings recouped 5
showing importance
individual raccoons
scenarios of 70,
2
ORV zone (400 + benefit:cost model
km band west of
of many biological
100, 175 baits/km .
2
km ), raccoon to prevent westward
zone)
factors determining
Distribution
2
$23.23/km
potential for success
spread of raccoon
and net savings
rabies
Simple model
12
$26.3 million total
Net savings $98–
Retrospective
(35)
Texas,
benefit:cost
showing wide-area
cost (2006 US$;
$354 million; BCRs of
progressive
expansion. ORV
Texas Department
3.7–13.4; range of
model; projected
elimination,
proved cost-efficient
of State Health
savings for 100%,
collapsed bands, population-based
if projections were
Services
50% and 25% of PEP
coyote
PEP and animal
accumulated value)
reduced to 7% of the
and rabies tests in
test costs for 20
epizootic area.
PEP and tests for
southern to 232epizootic counties
county expansion
area
12
$77.4 million (2006 Net savings in 3 of 4
Assumed multiple
S.A. Shwiff,
Ontario,
Benefit:cost
Can$) for total ORV scenarios: reductions
unpub. data
estimates of future
progressive
measured costs but
rabies-related costs
in animal rabies
elimination,
had to model
savings
testing accounted for
expanded
most net savings.
wedge, arcticfox variant,
red fox

*No inflation corrections used. ORV, oral rabies vaccination; PEP, postexposure prophylaxis; BCRs, benefit:cost ratios.
†Distribution costs exclude cost of bait purchases. US$ except as indicated.
‡For example, Meltzer (33) posited a baseline assumption with a distribution cost of $39/km2.
§Kemere et al. (34) assumed that the “… effectiveness of vaccination programs would be validated through surveillance and testing of raccoon
populations in the ORV zones … [evaluation cost] also includes educational, promotional, and overhead expenses.”
¶Although Kemere et al. (34) did not explicitly allow for contingency costs (to allow for breaches of ORV zones, etc.), they did sensitivity analyses
assuming “… the full program costs are used for the entire period instead of dropping to 40% after 5 years.”
#Foroutan et al. (26) only considered benefits extending up to 5 km west of the ORV zone. A simple extrapolation would suggest that net savings would
occur if the calculated benefits were to extend some 100–150 km west of the ORV zone.
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ditures for the ORV program were compared with benefits
accrued from likely PEP administrations and animal rabies
tests estimated for the 20-county epizootic area and projected to an area involving most of the state. Estimated benefits
ranged from $95 million to $369 million ($89 million to
$346 million, US$ in 2006); total ORV program costs were
reported as $28 million ($26,358,221 US$ in 1995–2006).
BCRs ranged from 3.4 to 13.1, depending on assumed incidence of PEP administrations and animal tests (35). This
study confirmed that 56/100,000 residents received PEP
during the epizootic, a high rate for the sparsely populated
area of southern Texas where the disease occurred (35).
Conclusions
ORV of wildlife has had positive public health effects.
Multiyear campaigns have led to progressive elimination of
arctic fox–variant and canine-variant rabies in Ontario and
Texas, respectively. PIC, TVR, and ORV zones have prevented raccoon-variant rabies from becoming established
in Ontario. Campaigns to contain and eliminate rabies in
gray foxes of west-central Texas continue, and spillover of
gray fox–variant rabies into coyotes may pose new challenges for preventing the spread of this variant. The ORV
zones and contingency actions along the Appalachian
Ridge have, thus far, prevented westward spread of raccoon rabies. Habitat alterations to reduce potential carrying
capacities of raccoons through local no-feeding regulations
and improved refuse management would aid rabies control
efforts, but these measures are difficult to implement and
enforce. Improved bait-vaccine technology, potentially integrating reproductive inhibitors into TVR campaigns for
specific urban raccoon and skunk populations, may improve wildlife rabies elimination.
Rabies campaigns have been relatively expensive. We
estimate that >$130 million (combined Can$ and US$) has
been spent on ORV programs in North America during the
past 10 years. Programs have proved lengthy (typically >5
years), have required enhanced surveillance, and have often required contingency actions to ensure rabies elimination without reintroduction.
Most economic assessments and modeling studies indicate that ORV programs can yield cost savings (32–35).
Regional increases in PEP administrations (and associated
public health costs) from 2–4/100,000 before to 24/100,000
(30), 45/100,000 (28), or 66/100,000 (27) residents during
or after have been documented for nonbat rabies epizootics. Reduced PEP, epizootic-related pet vaccinations, animal diagnostic tests, public education activities, and other
factors represent costs avoided by ORV programs. Direct
estimates of wild mammal populations and the relationship
of these to numbers of PEP administrations are difficult to
obtain; this topic was beyond the scope of our review but
needs research.
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etymologia

[lis′ə-vi′′rəs]

From the Greek lyssa (frenzy or madness) and Latin virus (poison). In Greek mythology, Lyssa was the goddess of
rage, fury, and rabies, known for driving mad the dogs of the hunter Acteon and causing them to kill their master.
Aristotle (4th century bce) said, “Dogs suffer from the madness. This causes them to become irritable and all
animals they bite to become diseased.” The disease in humans was characterized by hydrophobia, in which the sick
person was simultaneously tormented with thirst and with fear of water. Hippocrates is believed to refer to rabies
when he said that persons in a frenzy drink very little, are disturbed and frightened, tremble at the least noise, or
are seized with convulsions.
Lyssavirus is a genus of the family Rhabdoviridae, which includes rabies virus and other related viruses that infect
mammals and arthropods (e.g., Australian bat lyssavirus, Duvenhage virus, European bat lyssaviruses 1 and 2,
Lagos bat virus).
Source: Steele JH, Fernandez PJ. History of rabies and global aspects. In: Baer GM. The natural history of rabies, 2nd ed. New
York; CRC Press; 1991. Philadelphia: Saunders; 2007; Mahy B. The dictionary of virology, 4th edition. London: Academic Press;
2009. Dorland’s illustrated medical dictionary, 31st edition.
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Tactics and Economics of
Wildlife Oral Rabies Vaccination,
Canada and the United States
Technical Appendix 1
Wildlife Rabies-related Costs (Details of Published Studies;
No Inflation Corrections Used)
A cost-comparison study examined expenditures for controlling rabies before (1988) and
during (1990) a raccoon-variant rabies epizootic in Hunterdon and Warren counties, New Jersey,
USA (1). This study examined perhaps the most diverse set of costs thus far reported, but these
entailed relatively short-term, small-area estimates. The epizootic more than doubled rabiesrelated control costs, from $4.05 ($359/km2) to $9.79/county resident ($913/km2, 1990 US$).
Both before and during the epizootic, pet vaccinations were the largest single cost component of
rabies expenses; the costs for vaccinations of domestic animals were $337,998/100,000 residents
in 1988 and $640,552/100,000 residents in 1990. The next largest category was “other rabies
control activities” (e.g., public health, public education) accounting for 11% of costs in 1988 and
13% in 1990. The number of persons receiving postexposure prophylaxis (PEP) increased from 2
in 1988 (1/100,000 residents) to 131 in 1990 (66/100,000 residents). Although the average cost
was $555/person treated in 1988 and $1,138/person in 1990, PEPs only accounted for 8% of the
rabies-related costs at the peak of the epizootic in New Jersey in 1999.
In Massachusetts, a multiyear study focused on the increased use and cost of PEP during
1991 (1 year before a rabies epizootic) and from 1992 through 1995 of a raccoon rabies epizootic
in the state (2). The median cost of PEP was $2,376/person (range: $1,038–$4,447; 1995 US$);
69% of the cost was due to biologics. Estimates were similar for Connecticut (3). Numbers of
PEP administrations increased from 1.7/100,000 residents in 1991 to 45/100,000 residents in
1995 (26-fold increase). Thus, this rabies epizootic increased PEP-related costs by
$102,880/100,000 residents.
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During the 1990s, New York State reported an epizootic of raccoon-variant rabies (4).
The number of PEPs given in the state during the epizootic ranged from 2,422 in 1995 to a high
of 3,373 in 1997 (no preepizootic numbers reported; New York City (NYC) is excluded from
this statewide public health study). These are roughly equivalent to 24 and 34 PEPS per 100,000
residents (calculated using 2000 census count of 10 million state residents, excluding NYC). The
mean PEP cost was $1,136/person treated (1998 US$, biologics and administration), equivalent
to between $27,264/100,000 and $38,624/100,000 residents. This amount is notably lower than
the amount recorded in Massachusetts (2), but New York coordinates aspects of PEP (4).
Recently (1998–2002), when a skunk rabies epizootic spread from San Luis Obispo to
Santa Barbara County, the direct and indirect costs due to rabies exposure in southern California
were documented, (5). County records documented the medical and public health activities
required of 134 patients (equivalent to 4.1/100,000 county resident-years, using 2002 population
estimates for 5 years). The public health costs included case investigations and animal control
expenses. Telephone interviews of 55 patients who were given PEP provided indirect patientrelated expenses related to receiving PEP (e.g., alternative medicine, daycare, travel, time lost
from work). The mean total cost of a suspected human rabies exposure was $3,688/patient;
average direct (biologics, medical costs) and indirect costs were $2,564/patient and
$1,124/patient, respectively (2005 US$).
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Tactics and Economics of
Wildlife Oral Rabies Vaccination,
Canada and the United States
Technical Appendix 2
Correction for Inflation of Selected Costs in Original Publications
This Technical Appendix provides selected oral rabies vaccination (ORV), point
infection control (PIC), trap–vaccinate–release (TVR), and postexposure propylaxis (PEP) costs
for studies cited in the article; published costs are corrected for inflation. The annual Consumer
Price Index (CPI %) between 1990 and 2007 for “all goods and services (urban consumers)” was
used to derive 2008 values. Bank of Canada
(http://www.bankofcanada.ca/en/rates/inflation_calc.html) and the United States Bureau of
Labor Statistics (http://www.bls.gov/CPI/#overview) were sources of CPI rates.

Table 1. Annual Consumer Price Index inflation (% change
between years)*
Year
Canada
United States
1990
4.8
5.4
1991
5.6
4.2
1992
1.4
3.0
1993
1.9
3.0
1994
0.1
2.6
1995
2.2
2.8
1996
1.5
2.9
1997
1.7
2.3
1998
1.0
1.6
1999
1.8
2.2
2000
2.7
3.4
2001
2.5
2.8
2002
2.2
1.6
2003
2.8
2.3
2004
1.8
2.7
2005
2.2
3.4
2006
2.0
3.2
2007
2.2
2.8
2008
2.3
3.8
*Briefly, costs cited in the original publications were compounded for years
subsequent to the originally specified oral rabies vaccination, trap–
vaccinate–release, point infection control, and postexposure prophylaxis
cost estimates. If no monetary year was provided in the original article, we
arbitrarily specified a likely year for the authors’ calculations based on 1–2year publication lags. As of June 25, 2008, currency conversion was as
follows: 0.98 Can$ = 1.00 US$; whereas, as of May 5, 2009 1.00 Can$ =
1.19 US$.
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Table 2. List of originally cited studies and inflated cost estimates for ORV, TVR, PIC, or PEP variables in 2008 Can$ or US$*
Year or assumed year of original
Current cost
monetary estimate
(Can$ or US$ in 2008)
Study and reference
ORV/TVR/PIC†
(1)
No estimate
No estimate
2
(2)
1990
TVR $616/km Can$
2
(3)
1999
PIC $605/km Can$
2
ORV only $245/km Can$
2
Slate (prior unpub. data)
ORV $111/km US$
2
(4)
1999
ORV $198/km US$
(5)
PEP‡
(6)
(7)
(8)
(9)

2

2004

ORV $48/km US$

1990
1995
1995
2005

$1,874/patient US$
$3,356/patient US$
1,501/patient US$
$4,066/patient US$

*ORV, oral rabies vaccination; TVR, trap–vaccinate–release; PIC, point infection control; PEP, postexposure prophylaxis.
†Rosatte et al. (2001), Slate (prior unpublished data), and Foroutan et al. (2002) report ORV costs for raccoons (i.e., bait densities of 50–75/km2; Sidwa et
al. (2004) report ORV for coyote and gray fox (i.e., bait densities of 19-39/km2).
‡Chang et al. (2002) report PEP for New York (i.e., biologics are paid by state); Shwiff et al. (2007) report both direct and indirect costs of PEP.
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Tactics and Economics of
Wildlife Oral Rabies Vaccination,
Canada and the United States
Technical Appendix 3
Principles of an Economic Analysis of Oral Rabies Vaccination Programs
Rabies, Oral Rabies Vaccination and Use of Benefit:cost Analyses

There are often no human rabies cases directly related to an epizootic of terrestrial rabies.
Thus, it is often impossible to conduct a cost-effectiveness analysis—an often-recommended
method for public health economics studies, in which the analytic output would be cost per
averted case of human rabies (1). Thus, published studies have used benefit:cost methods, in
which researchers attempt to evaluate all of the benefits and costs from ORV programs in dollar
values (1,2). The general benefit:cost equation below illustrates the basic concept:
Net savings (costs) = value of reduced rabies-related costs –
costs of oral rabies vaccination (ORV) program.
Where: Value of reduced rabies–related costs = (some portion of) costs of rabies
epizootic = additional pet vaccinations + additional livestock vaccinations + pet replacements +
livestock replacements + additional human preexposure rabies prophylaxis + additional human
postexposure prophylaxis (PEP) + costs of treating adverse side effects of additional PEPs +
costs of case investigations by public health units + additional laboratory tests + quarantine of
suspected rabid animals + public educational materials + potential loss of endangered mammals
in areas near epizootics (3).
To date, prevention of costs of additional pet vaccinations and PEP have been the main
economic impacts of rabies epizootics used to evaluate benefits of ORV programs (4–7). It is
controversial to consider additional pet vaccinations as a cost of rabies epizootic (typically,
before a rabies epizootic, vaccination rates in dogs in the United States are between 20% and
50% (8). Experience has shown that ORV programs cannot guarantee elimination of all rabies
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risks to pets (e.g., ORV zones have been breached, bat rabies is not controlled by current ORV
programs). It has been argued that it is potentially a benefit, and not a cost, if pet rabies
vaccination rates increase, regardless of cause (S.A. Shwiff, unpub. data). Also, pet replacement
costs have never, to our knowledge, actually been measured, and there has yet to be a valuation
of a loss of endangered species due to a rabies epizootic.
ORV-Related Program Cost

Costs of an ORV program (often multiyear) can be defined as follows (3–5):
Costs of an ORV program per year = (area covered in 1 year × vaccine-bait density per
unit area × price of individual vaccine-baits) + distribution costs + costs of injuries/
accidents + costs of contingency plans
Vaccine-baits have, to date, been distributed by fixed-wing aircraft, helicopters, and
ground (i.e., personnel either walking or driving). Although accidents and injuries associated
with ORV operations have been rare, the potential for these costs remain and must be considered
in any economic assessment of ORV. Injuries to employees performing baiting operations are
typically covered by some form of preexisting insurance (i.e., costs are prepaid and thus not
usually included), but potential public injury or death due to various events remains a possibility.
To date, in the United States, only 1 accident involving a citizen’s exposure to the live vaccine in
ORV baits has occurred. The citizen sued the public health agency responsible for distributing
the baits. The court, however, ruled in favor of the public health department, incurring zero cost
to the public (9).
Analytic Timeline

Rabies epizootics usually last >2 years and may exhibit cyclic patterns (i.e., number of
rabid animals increase and decrease as the animal population changes). The costs of controlling
rabies can be considered as having 3 different time periods: preepizootic, during epizootic, and
postepizootic. It is possible that during the postepizootic period rabies control costs will not
subside to preepizootic levels (1). Similarly, an ORV program will typically last >5 years. Thus,
an economic study of ORV programs must incorporate the multiyear aspects of benefits and
costs.
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Perspective and Discounting

Because a substantial part of the costs of a rabies epizootic and an ORV program are
borne by public health entities, it is appropriate that any analyses of an ORV program take a
societal perspective as the principal perspective. Furthermore, because rabies epizootics and
ORV programs may each take several years, benefits and costs must be appropriately discounted
(1,2,6).
Units of Analysis

The economics of ORV are determined by human population density (i.e., increased
human population results in increased probability and numbers of PEPs, pet vaccinations, etc.). It
has been shown that human population density can impact the number of animals tested for
rabies (10). Thus, it is recommended that both benefits and costs of ORV programs be calculated
in terms of $/unit area (S.A. Shwiff, unpub.data). This allows for ready comparison within a
program over time (as populations change), comparison between programs (with possible
differences by targeted species and locale), and consideration of targeting and prioritization (by
economic criteria).
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